Market research
EYES Second Sight Medical Products
US USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 54M
- P/E ratio
- Not available
- Analyst target
- 2.5
- Dividend yield
- 0.0%
- Beta
- 0.0
Community
Investor discussion
1 comment
Sign in to join the EYES discussion.
5 years, 4 months ago
Second Sight Medical Products, Inc is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 87.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 167.4.
Second Sight Medical Products, Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 83.6% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 80.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Second Sight Medical Products, Inc gets an overall score of 4/5.